RIO DE JANEIRO, Dec. 11 Amilpar (Bovespa: AMIL3;Bloomberg: AMIL3 BZ and APAR < GO >; Reuters: AMIL3.SA), the largest managedcare organization in Brazil, in accordance with CVM (Brazilian Securities andExchange Commission) Instruction 358/02, informs that the 1st Issuance ofCommercial Papers for public distribution with restricted selling efforts(according to CVM Instruction 476/09), was approved in a Board Meeting heldtoday, with the objective of increasing the Company's cash position after theacquisition of Medial Saude S.A. control, under the following terms andconditions:Total Amount: R$ 300 million Term: 360 days, with the option of anticipating redemption Remuneration: 110% of CDI (average interbank deposit rate in Brazil) Coordinator: Banco Bradesco BBI S.A. To access the Press Release visit our website at www.amilpar.com.br/ir IR Contact Erwin Kleuser Investor Relations Officer Phone: +55 (21) 3805-1155 [email protected] www.amilpar.com.br/ir
